ML22174A286

630776-New License 50-35674-01 for Alyeska Imaging Center

ML22174A286
Person / Time
Site:	03039310
Issue date:	06/23/2022
From:	Ricardo Torres NRC/RGN-IV/DRSS
To:	Document Control Desk
References
License-630776-170719
Download: ML22174A286 (1)

See also: IR 05000356/1974001

Text

NRC FORM 374 PAGE OF1 3 PAGES

U.S. NUCLEAR REGUL ATORY COMMISSION

MATERIALS LICENSE

Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I,

Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued

authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s)

and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This

license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and

orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below.

Licensee In accordance with application 4. Expiration Date: June 30, 2037

1. Alyeska Imaging Center dated March 8, 2022; and letter

dated June 22, 2022,

5. Docket No.: 030-39310

2. 2480 S. Woodworth Loop 3. License No.: 50-35674-01 Reference No.:

Suite 140

Palmer, AK 99645

6. 7. 8.Byproduct, source,Chemical and/or physical form Maximum amount that licensee 9. Authorized use

and/or special nuclear may possess at any one time

material under this license

A. For use in uptake, dilution and Any byproduct materialA.Any As NeededA.A.

permitted by 10 CFR excretion studies permitted by 10 CFR

35.100 35.100.

B. For use in imaging and localization Any byproduct materialB.Any As NeededB.B.

permitted by 10 CFR studies permitted by 10 CFR 35.200.

35.200

NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 32OFPAGES

License No.: Docket or Reference No.:50-35674-01

MATERIALS LICENSE 030-39310

SUPPLEMENTARY SHEET

CONDITIONS

10. Licensed material shall be used or stored at the licensee's facilities located at 2480 S. Woodworth Loop , Suite 140, Palmer, Alaska, 99645.

11. The Radiation Safety Officer (RSO) for this license is Jason Bernard Ivey.

12. Licensed material shall only be used by, or under the supervision of:

A. Individuals permitted to work as authorized users in accordance with 10 CFR 35.13 and 10 CFR 35.14.

B. The following individuals are authorized users for the material and medical uses as indicated:

Authorized User (M.D.,D.O.,etc.) Material and Use

Daniel Andrew Davignon, Jr., D.O. 10 CFR 35.100,10 CFR 35.200

NRC FORM 374A U.S. NUCLEAR REGUL ATORY COMMISSION P AGE 33OFPAGES

License No.: Docket or Reference No.:50-35674-01

MATERIALS LICENSE 030-39310

SUPPLEMENTARY SHEET

13. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements,

representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to

those statements, representations, and procedures that are required to be submitted in accordance with the regulations. Additionally, this

license condition does not limit the licensee's ability to make changes to the radiation protection program as provided for in 10 CFR 35.26.

The U.S. Nuclear Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the

licensee's application and correspondence impose on the licensee requirements that are more restrictive than or in addition to the

regulations.

A. Application dated March 8, 2022 with enclosures (ML22 117A097)

B. Letter dated June 22, 2022 with enclosures (ML22173A174)

FOR THE U.S. NUCLEAR REGULATORY COMMISSION

Date: June 23, 2022 By:

Roberto J. Torres

Region IV